Merus N V Announces Proposed Public Offering of Common Shares businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.
GTCR LLC entered into a definitive agreement to acquire Surmodics, Inc. for approximately $620 million on May 28, 2024. Under the terms of the agreement, affiliates of GTCR will acquire all.
BASE SHELF PROSPECTUS AND PRELIMINARY PROSPECTUS SUPPLEMENT ACCESSIBLE AND FINAL PROSPECTUS SUPPLEMENT TO BE ACCESSIBLE WITHIN TWO BUSINESS DAYS ON SEDAR+ VANCOUVER, British Columbia, May 28, 2024 .
BASE SHELF PROSPECTUS AND PRELIMINARY PROSPECTUS SUPPLEMENT ACCESSIBLE AND FINAL PROSPECTUS SUPPLEMENT TO BE ACCESSIBLE WITHIN TWO BUSINESS DAYS ON SEDAR+ VANCOUVER, British Columbia, May 28, 2024 (GLOBE NEWSWIRE)
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 28, 2024 Merus N.V. , a clinical-stage oncology company developing innovative, full-length multispecific antibodies , today announced the.